Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $116,371 - $140,177
10,217 New
10,217 $130,000
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $449,678 - $589,501
38,732 New
38,732 $450,000
Q1 2022

May 16, 2022

SELL
$15.39 - $20.25 $435,967 - $573,642
-28,328 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$15.91 - $18.72 $450,698 - $530,300
28,328 New
28,328 $489,000
Q4 2019

Feb 14, 2020

SELL
$10.28 - $14.38 $147,291 - $206,036
-14,328 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$10.05 - $14.55 $143,996 - $208,472
14,328 New
14,328 $151,000
Q2 2019

Aug 14, 2019

SELL
$13.1 - $14.95 $132,087 - $150,740
-10,083 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$13.69 - $20.06 $138,036 - $202,264
10,083 New
10,083 $141,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.